CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 235.5 SEK -1.46%
Market Cap: 5.6B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CellaVision AB
Operating Expenses Peer Comparison

Comparables:
EKTA B
S
SUS
GETI B
ARJO B
S
STIL

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Operating Expenses
-kr300.2m
CAGR 3-Years
-14%
CAGR 5-Years
-11%
CAGR 10-Years
-13%
Elekta AB (publ)
STO:EKTA B
Operating Expenses
-kr4.4B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Operating Expenses
-kr426.5m
CAGR 3-Years
-67%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Operating Expenses
-kr10.3B
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Operating Expenses
-kr3.8B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Operating Expenses
-kr144.2m
CAGR 3-Years
-45%
CAGR 5-Years
-30%
CAGR 10-Years
-19%

See Also

What is CellaVision AB's Operating Expenses?
Operating Expenses
-300.2m SEK

Based on the financial report for Jun 30, 2024, CellaVision AB's Operating Expenses amounts to -300.2m SEK.

What is CellaVision AB's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-13%

Over the last year, the Operating Expenses growth was -5%. The average annual Operating Expenses growth rates for CellaVision AB have been -14% over the past three years , -11% over the past five years , and -13% over the past ten years .

Back to Top